Analysis of clinical complication data for radiation hepatitis using a parallel architecture model

doi:10.1016/0360-3016(94)00471-4

International Journal of Radiation OncologyBiologyPhysics

Volume 31, Issue 4, 15 February 1995, Pages 883-891

https://doi.org/10.1016/0360-3016(94)00471-4 Get rights and content

Abstract

$Purpose$ : The detailed knowledge of dose volume distributions available from the three-dimensional (3D) conformal radiation treatment of tumors in the liver (reported elsewhere) offers new opportunities to quantify the effect of volume on the probability of producing radiation hepatitis. We aim to test a new parallel architecture model of normal tissue complication probability (NTCP) with these data.

$Methods and Materials$ : Complication data and dose volume histograms from a total of 93 patients with normal liver function, treated on a prospective protocol with 3D conformal radiation therapy and intraarterial hepatic fluorodeoxyuridine, were analyzed with a new parallel architecture model. Patient treatment fell into six categories differing in doses delivered and volumes irradiated. By modeling the radiosensitivity of liver subunits, we are able to use dose volume histograms to calculate the fraction of the liver damaged in each patient. A complication results if this fraction exceeds the patient's functional reserve. To determine the patient distribution of functional reserves and the subunit radiosensitivity, the maximum likelihood method was used to fit the observed complication data.

$Results$ : The parallel model fit the complication data well, although uncertainties on the functional reserve distribution and subunit radiosensitivy are highly correlated.

$Conclusion$ : The observed radiation hepatitis complications show a threshold effect that can be described well with a parallel architecture model. However, additional independent studies are required to better determine the parameters defining the functional reserve distribution and subunit radiosensitivity.

References (35)

M.M. Austin-Seymour et al.
Dose volume histogram analysis of liver radiation tolerance
Int. J. Radiat. Oncol. Biol. Phys.
(1986)
G.W. Barendsen
Dose fractionation, dose rate and iso-effect relationships for normal tissue responses
Int. J. Radiat. Oncol. Biol. Phys.
(1982)
C. Burman et al.
Fitting normal tissue tolerance data to an analytic function
Int. J. Radiat. Oncol. Biol. Phys.
(1991)
A.R. Calkins et al.
Delayed split whole abdominal irradiation in the combined modality treatment of ovarian cancer
Int. J. Radiat. Oncol. Biol. Phys.
(1991)
B. Emami et al.
Tolerance of normal tissue to therapeutic radiation
Int. J. Radiat. Oncol. Biol. Phys.
(1991)
M. Feigen et al.
Radiation hepatitis following moving strip radiotherapy
Int. J. Radiat. Oncol. Biol. Phys.
(1983)
E. Haddad et al.
Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: Preliminary results
Int. J. Radiat. Oncol. Biol. Phys.
(1983)
T.J. Kim et al.
Acute transient radiation hepatitis following whole abdominal irradiation
Clin. Radiol.
(1976)
G.J. Kutcher et al.
Calculation of complication probability factors for nonuniform normal tissue irradiation: The effective volume method
Int. J. Radiat. Oncol. Biol. Phys.
(1989)
G.J. Kutcher et al.
Histogram reduction method for calculating complication probabilities for three dimensional treatment planning evaluations
Int. J. Radiat. Oncol. Biol. Phys.
(1991)

T.S. Lawrence et al.

An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy

Int. J. Radiat. Oncol. Biol. Phys.

(1990)

T.S. Lawrence et al.

The use of 3-D dose volume analysis to predict radiation hepatitis

Int. J. Radiat. Oncol. Biol. Phys.

(1992)

J.T. Lyman et al.

Optimization of radiation therapy. III. A method for assessing complication probabilities from dose-volume histograms

Int. J. Radiat. Oncol. Biol. Phys.

(1987)

J.T. Lyman et al.

Optimization of radiation therapy. IV. A dose-volume histogram reduction algorithm

Int. J. Radiat. Oncol. Biol. Phys.

(1989)

A. Niemierko et al.

Modeling of normal tissue response to radiation: The critical volume model

Int. J. Radiat. Oncol. Biol. Phys.

(1993)

A.H. Russell et al.

Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol

Int. J. Radiat. Oncol. Biol. Phys.

(1993)

R.K. Ten Haken et al.

Use of Veff and iso-NTCP in the implementation of dose escalation protocols

Int. J. Radiat. Oncol. Biol. Phys.

(1993)

Cited by (233)

The Effect of Stereotactic Body Radiation Therapy for Hepatocellular Cancer on Regional Hepatic Liver Function
2023, International Journal of Radiation Oncology Biology Physics
To investigate direct radiation dose–related and inflammation-mediated regional hepatic function losses after stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) and poor liver function.
Twenty-four patients with HCC enrolled on an IRB-approved adaptive SBRT trial had liver dynamic gadoxetic acid–enhanced magnetic resonance imaging and blood sample collections before and 1 month after SBRT. Gadoxetic acid uptake rate (k1) maps were quantified for regional hepatic function and coregistered to both 2-Gy equivalent dose and physical dose distributions. Regional k1 loss patterns from before to after SBRT were analyzed for effects of dose and patient using a mixed-effects model and logistic function and were associated with pretherapy liver-function albumin-bilirubin scores. Plasma levels of tumor necrosis factor α receptor 1 (TNFR1), an inflammation marker, were correlated with mean k1 losses in the lowest dose regions by Spearman rank correlation.
The whole group had a k1 loss rate of 0.4%/Gy (2-Gy equivalent dose); however, there was a significant random effect of patient in the mixed-effect model (P < .05). Patients with poor and good liver functions lost 50% of k1 values at 12.5 and 57.2 Gy and 33% and 16% of k1 values at the lowest dose regions (<5 Gy), respectively. The k1 losses at the lowest dose regions of individual patients were significantly correlated with their TNFR1 levels after SBRT (P < .02).
The findings suggest that regional hepatic function losses after SBRT in patients with HCC include both direct radiation dose–dependent and inflammation-mediated effects, which could influence how to manage these patients to preserve their liver function after SBRT.
Gadoxetic Acid Uptake Rate as a Measure of Global and Regional Liver Function as Compared With Indocyanine Green Retention, Albumin-Bilirubin Score, and Portal Venous Perfusion
2022, Advances in Radiation Oncology
Citation Excerpt :
The results of this analysis underscore the differences between total functional volume and liver volume. The conventional normal tissue complication probability models, although providing guidance for radiation dose planning and avoiding liver injury, assume uniform hepatic function distribution over the liver volume.5,30,31 Although in most metastatic cases liver function is likely uncompromised outside the region of the tumor, this is not the case for patients with primary liver cancer.
Global and regional liver function assessments are important for defining the magnitude and spatial distribution of dose to preserve functional liver parenchyma and reduce incidence of hepatotoxicity from radiation therapy for intrahepatic cancer treatment. This individualized liver function-guided radiation therapy strategy is critical for patients with heterogeneous and poor liver function, often observed in cirrhotic patients treated for hepatocellular carcinoma. This study aimed to validate k₁ as a measure of global and regional function through comparison with 2 well-regarded global function measures: indocyanine green retention (ICGR) and albumin-bilirubin (ALBI).
Seventy-nine dynamic gadoxetic acid enhanced magnetic resonance imaging scans were acquired in 40 patients with hepatocellular carcinoma in institutional review board approved prospective protocols. Portal venous perfusion (k_pv) was quantified from gadoxetic acid enhanced magnetic resonance imaging using a dual-input 2-compartment model, and gadoxetic acid uptake rate (k₁) was fitted using a linearized single-input 2-compartment model chosen for robust k₁ estimation. Four image-derived measures of global liver function were tested: (1) mean k₁ multiplied by liver volume (k₁V_L) (functional volume), (2) mean k₁ multiplied by blood distribution volume (k₁V_dis)_, (3) mean k_pv, and (4) liver volume (V_L). The measure's correlation with corresponding ICGR and ALBI tests was assessed using linear regression. Voxel-wise similarity between k₁ and k_pv was compared using Spearman ranked correlation.
Significant correlations (P < .05) with ICGR and ALBI were found for k₁V_L, k₁V_dis, and V_L (in order of strength), but not for mean $k$ _pv $.$ The mean ranked correlation coefficient between k₁ and k_pv maps was 0.09. k₁ and k_pv maps were predominantly mismatched in patients with poor liver function.
The metric combining function and liver volume (k₁V_L) was a stronger measure of global liver function compared with perfusion or liver volume alone, especially in patients with poor liver function. Gadoxetic acid uptake rate is promising for both global and regional liver function.
Forecasting the daily natural gas consumption with an accurate white-box model
2021, Energy
Compared with artificial intelligence black-box models, statistical white-box models have less application and lower accuracy in forecasting daily natural gas consumption that contains high dimensional and large samples. Parallel model architecture (PMA) is a forecasting strategy that improves the accuracy of forecasting models. However, due to the large numbers of non-stationarity subseries generated by PMA in daily natural gas consumption forecasting, the forecasting problem becomes more difficult. This paper proposes a weighted parallel model architecture (WPMA) strategy that reduces the numbers and the non-stationarity of subseries by introducing k-means clustering and weighting the forecasts of subseries for out-of-sample forecasting. By combining WPMA with principal component analysis (PCA) and multiple linear regression (MLR), a white-box hybrid model is generated called PCA-WPMA-MLR. Principal component analysis is a dimension-reduction algorithm that is used to extract the components from input variables, and MLR is a white-box forecaster. Additionally, the historical datasets of four representative cities distributed in three climate zones are collected in case studies. The results show that the PCA-WPMA-MLR model provides comparable forecasting performance with the deep learning model. WPMA outperforms PMA in improving forecasting accuracy, and it reduces the mean absolute percentage error of MLR by 39.07% in the Melbourne case.
Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments
2021, International Journal of Radiation Oncology Biology Physics
Dose-volume data for injury to carotid artery and other major vessels in stereotactic body radiation therapy (SBRT)/SABR head and neck reirradiation were reviewed, modeled, and summarized.
A PubMed search of the English-language literature (stereotactic and carotid and radiation) in April 2018 found 238 major vessel maximum point doses in 6 articles that were pooled for logistic modeling. Two subsequent studies with dose-volume major vessel data were modeled separately for comparison. Attempts were made to separate carotid blowout syndrome from other bleeding events (BE) in the analysis, but we acknowledge that all except 1 data set has some element of BE interspersed.
Prior radiation therapy (RT) dose was not uniformly reported per patient in the studies included, but a course on the order of conventionally fractionated 70 Gy was considered for the purposes of the analysis (with an approximately ≥6-month estimated interval between prior and subsequent treatment in most cases). Factors likely associated with reduced risk of BE include nonconsecutive daily treatment, lower extent of circumferential tumor involvement around the vessel, and no surgical manipulation before or after SBRT.
Initial data pooling for reirradiation involving the carotid artery resulted in 3 preliminary models compared in this Hypofractionated Treatment Effects in the Clinic (HyTEC) report. More recent experiences with alternating fractionation schedules and additional risk-reduction strategies are also presented. Complications data for the most critical structures such as spinal cord and carotid artery are so limited that they cannot be viewed as strong conclusions of probability of risk, but rather, as a general guideline for consideration. There is a great need for better reporting standards as noted in the High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic introductory paper.
Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards
2021, International Journal of Radiation Oncology Biology Physics
We sought to investigate the tumor control probability (TCP) of spinal metastases treated with stereotactic body radiation therapy (SBRT) in 1 to 5 fractions.
PubMed-indexed articles from 1995 to 2018 were eligible for data extraction if they contained SBRT dosimetric details correlated with actuarial 2-year local tumor control rates. Logistic dose-response models of collected data were compared in terms of physical dose and 3-fraction equivalent dose.
Data were extracted from 24 articles with 2619 spinal metastases. Physical dose TCP modeling of 2-year local tumor control from the single-fraction data were compared with data from 2 to 5 fractions, resulting in an estimated α/β = 6 Gy, and this was used to pool data. Acknowledging the uncertainty intrinsic to the data extraction and modeling process, the 90% TCP corresponded to 20 Gy in 1 fraction, 28 Gy in 2 fractions, 33 Gy in 3 fractions, and (with extrapolation) 40 Gy in 5 fractions. The estimated TCP for common fractionation schemes was 82% at 18 Gy, 90% for 20 Gy, and 96% for 24 Gy in a single fraction, 82% for 24 Gy in 2 fractions, and 78% for 27 Gy in 3 fractions.
Spinal SBRT with the most common fractionation schemes yields 2-year estimates of local control of 82% to 96%. Given the heterogeneity in the tumor control estimates extracted from the literature, with variability in reporting of dosimetry data and the definition of and statistical methods of reporting tumor control, care should be taken interpreting the resultant model-based estimates. Depending on the clinical intent, the improved TCP with higher dose regimens should be weighed against the potential risks for greater toxicity. We encourage future reports to provide full dosimetric data correlated with tumor local control to allow future efforts of modeling pooled data.
Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer
2021, International Journal of Radiation Oncology Biology Physics
Stereotactic body radiation therapy (SBRT) and stereotactic ablative body radiation therapy is being increasingly used for pancreatic cancer (PCa), particularly in patients with locally advanced and borderline resectable disease. A wide variety of dose fractionation schemes have been reported in the literature. This HyTEC review uses tumor control probability models to evaluate the comparative effectiveness of the various SBRT treatment regimens used in the treatment of patients with localized PCa.
A PubMed search was performed to review the published literature on the use of hypofractionated SBRT (usually in 1-5 fractions) for PCa in various clinical scenarios (eg, preoperative [neoadjuvant], borderline resectable, and locally advanced PCa). The linear quadratic model with α/β= 10 Gy was used to address differences in fractionation. Logistic tumor control probability models were generated using maximum likelihood parameter fitting.
After converting to 3-fraction equivalent doses, the pooled reported data and associated models suggests that 1-year local control (LC) without surgery is ≈79% to 86% after the equivalent of 30 to 36 Gy in 3 fractions, showing a dose response in the range of 25 to 36 Gy, and decreasing to less than 70% 1-year LC at doses below 24 Gy in 3 fractions. The 33 Gy in 5 fraction regimen (Alliance A021501) corresponds to 28.2 Gy in 3 fractions, for which the HyTEC pooled model had 77% 1-year LC without surgery. Above an equivalent dose of 28 Gy in 3 fractions, with margin-negative resection the 1-year LC exceeded 90%.
Pooled analyses of reported tumor control probabilities for commonly used SBRT dose-fractionation schedules for PCa suggests a dose response. These findings should be viewed with caution given the challenges and limitations of this review. Additional data are needed to better understand the dose or fractionation-response of SBRT for PCa.

View all citing articles on Scopus

^☆: Presented at the 35th Annual ASTRO Meeting, New Orleans, LA, October 14, 1994.

View full text

Physics original contributionAnalysis of clinical complication data for radiation hepatitis using a parallel architecture model☆

Abstract

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Clin. Radiol.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Int. J. Radiat. Oncol. Biol. Phys.

Physics original contribution
Analysis of clinical complication data for radiation hepatitis using a parallel architecture model☆